Globally, the healthcare sector has witnessed spectacular growth, though not intentionally but out of dire necessity. From a formerly projected 36 million for 2020, telehealth visits are expected to cross1 billion visits this year. Medical centers and hospitals are getting overpowered by the uncontrollable spread of the pandemic.
Indian healthcare sector and technology
An Indian IT firm, Thalamus Irwine, has recently reported that they have built up an Artificial Intelligence (AI) and Internet of Things (IoT) solution that can enable the central and state governments to test and recognize weak communities to be prioritized for the COVID-19 vaccination. The serosurvey platform developed is named ‘Garuda’.
The Indian authorities have approved two COVID-19 vaccines – Covishield by AstraZeneca and Oxford University, and Covaxin by Bharat Biotech; administering a two-dose vaccine to a population exceeding 1.3 billion is a logistical nightmare.
Co-Win
The major highlight is that, when considering a huge number of tests in a sero-study which can take up to several months, Garuda can lead a seroprevalence study of one-crore tests within seven days, as per the firm.
Co-WIN is a Cloud-based solution for arranging usage, monitoring, and assessment of the COVID-19 vaccine in India. Experts suggest that the updated platform should be scaled up to use the capability of emerging innovations, such as Artificial Intelligence (AI), Machine Learning (ML), and Internet of Things (IoT) to achieve the mammoth undertaking of vaccine administration.
AI and IoT
The blend of artificial intelligence (AI) and internet of things (IoT) innovation might be the greatest disruption to be witnessed in the industrial refrigeration industry since the creation of the principal commercial ice-making machine about two centuries ago. The integration of AI with IoT innovation will be conveying real-time alerts for cost-effective predictive and preventive maintenance. Companies can hence quicken their pace in making data-driven business decisions that are highly dependent on what is going on in real-time.
The majority of the COVID-19 vaccines require storage at extreme temperatures; the Oxford vaccine managed by the Serum Institute of India needs a storage temperature of about 2-8 degrees Celsius. To guarantee an effective stockpiling framework, sensor-based IoT innovation can prove to be useful, as it permits consistent monitoring of information in real-time. The sensors can comprehend temperature and send a framework alert for the next shipment of vaccines if there is any temperature adjustment. Also, the whole process includes an exponential amount of data, which must be overseen and stored in a Cloud platform that is available to all partners. In such situations, platforms like Amazon Web Services (AWS) and Google Cloud can be helpful, considering the sensitivity of data collected.
To address the major problem of innovation take-up, the Government of India has initiated a startup challenge to fortify the intelligence platform exclusively through native technology solutions. The focus areas of the test will be incorporating technologies related to monitoring and management, infrastructure, vaccine logistics management, etc.
Follow and connect with us on Facebook, Linkedin & Twitter
